The Serum Institute of India, the world’s largest vaccine manufacturer, on Tuesday prepared its first batch of vaccine shots for the Kovacs Global Inoculation Program.
The global vaccine procurement and equitable distribution effort aims to secure vaccines for at least the weakest 20 percent in every country.
Kovacs, led by the World Health Organization and the GAVI Alliance, has entered into agreements with manufacturers for two billion doses in 2021 and has a further billion options.
It contains 1.1 billion doses from the Serum Institute, which is producing AstraZeneca and Novavax vaccines.
WHO South East Asia tweeted pictures of the first shipment being loaded on a truck at Serum’s manufacturing facility in Pune, Western India.
The serum has already supplied millions of doses of the AstraZeneca vaccine to the Indian government as well as to other poor countries.
The company’s head Adar Poonawala on Sunday urged other countries to be “patient”, saying it had been directed to prioritize its domestic market over exports.
(Except for the headline, this story has not been edited by NB staff and published from a syndicated feed.)